Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: A case report

Jen Seng Huang, Pei Hung Chang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

11 Scopus citations

Abstract

Non-islet cell tumor hypoglycemia (NICTH) is an uncommon but serious complication of malignancy. Patients with NICTH may appear unwell due to the underlying tumor, particularly when the mechanism of hypoglycemia is extensive tumor burden in the liver. Hepatocellular carcinoma (HCC) is reported to be the second most common cause of NICTH. The therapeutic strategies used in treating NICTH involve reduction of the tumor mass or tumor load, and palliative treatment of symptoms if curative attempts fail. In the present study we report the successful control of hypoglycemia using systemic chemotherapy in an advanced HCC patient who presented with refractory NICTH.

Original languageEnglish
Pages (from-to)898-900
Number of pages3
JournalOncology Letters
Volume11
Issue number1
DOIs
StatePublished - 01 2016

Bibliographical note

Publisher Copyright:
© Spandidos Publications 2015. All right reserved.

Keywords

  • Chemotherapy
  • Hepatoma
  • Non-islet tumor hypoglycemia

Fingerprint

Dive into the research topics of 'Refractory hypoglycemia controlled by systemic chemotherapy with advanced hepatocellular carcinoma: A case report'. Together they form a unique fingerprint.

Cite this